Telstar leads the international Life Sciences Engineering business of the azbil Group
|
|
- Horatio Carr
- 8 years ago
- Views:
Transcription
1 . May 2013 Number 24 CORPORATE Telstar leads the international Life Sciences Engineering business of the azbil Group Azbil Group is a leading company in Building Automation, Advanced Automation and Life Automation for Healthcare and other markets connected closely to everyday life Telstar, as part of azbil Group, is leading the launching of a new business Life Science Engineering Telstar has expanded its business in the Life Sciences field to provide new solutions related to manufacturing equipment with environmental systems and automation technologies for the markets contributing to people's health. This decision was made following the agreement reached by Japanese Azbil to acquire 80% of Telstar SA from the founding shareholders in December Azbil is a leading Japanese group in building automation for the building market, advanced automation for the industry market and life automation systems for the life sciences and healthcare markets as well as fields connected closely to everyday life. The group develops its own regulation, control and automation technologies, equipment and systems used in industry and in buildings. Azbil Group, which is listed on the Tokyo stock exchange, was founded in 1906 and currently has a workforce of 5,185 people and a revenue of $2,725.6M in year 2012 (FY 30/3/2012). As a subsidiary of Azbil, Telstar leads the Life Science Engineering business division of the Japanese corporation to provide global solutions in design, engineering and manufacturing processes with automation technologies for the international life science markets, such as biopharmaceutical, life science research, regenerative medicine and functional foods. In this context, Azbil plans to introduce products, services and solutions in fields with great potential with future growth, such as biopharmaceutical, life science research, personalized medicine for medication and treatment customization based on individual patients' treatment plans, and regenerative medicine represented today by technologies such as the ips cell (induced pluripotent stem cell), and expand to the global market in the near future. Through this partnership, Azbil has strengthened its overseas sales operations by utilizing Telstar's sales network established in the pharmaceutical, laboratory and hospital sectors in Europe, Latin America, and North America, while Telstar will expand its business domain through Azbil's operating bases in the Asian region, as well as strengthen its solution-providing capabilities by applying Azbil's technologies to new product development and system integration. Based on the principles and values of Azbil, the technological and operating synergies and the complementary geographic network of sales between Azbil and Telstar, the Spanish company has identified in Azbil a strategic business partner to continue driving the business forward. By providing product and services created through the synergy of the two companies, Azbil and Telstar aim to deliver superior customer value. Telstar retains its headquarter in Terrassa (Barcelona) to develop its activities in Life Science Engineering, which will continue to operate under the Telstar brand. Editorial. Telstar consolidates global supply position Telstar Group. Telstar completes its web site with the addition of project services information for the Life Science market Exhibitions and Conferences BACK COVER Life Science Solutions LABORATORY. Telstar develops a containment unit for use in biomedical research at the Institute of Materials Science of Barcelona, part of CSIC PHARMA. Telstar develops three integrated lines for bulk production of potent sterile antibiotics for Hisun Pharmaceutical. Square Pharmaceuticals contracts Telstar for the entire deveopment of new pharmaceutical plants for production of oral and parenteral products. Telstar reinforces its pharmaceutical consulting area by adding a new line of consulting and deployment services for quality by design (QbD) systems Vacuum Solutions. Telstar provides a simulation chamber for vacuum thermal tests on micro-satellites
2 EDITORIAL Telstar consolidates global supply position Two years after the integration of Telstar's activity under a single brand, the company has consolidated its position as an international supplier of global high-tech solutions for the industry linked with the life science market, especially in Europe, America and Asia. With 50 years of experience, Telstar is now recognised as one of the ten major international suppliers of global solutions for the biopharmaceutical industry and the only international specialized company with the ability to offer complete solutions in engineering, construction, process equipment design and manufacture, equipment and critical systems installation and services (commissioning and qualification, staff training and quality assurance) for turnkey bio technical and pharmaceutical plants with its own technologies, subject matter experts and resources. Telstar, which has seven production plants and nine technology centers worldwide, invests 3% of its turnover in R&D+i. The company is currently constructing two new pharmaceutical plants for the international Bengali company Square Pharmaceuticals and three integrated high potent lines for sterile antibiotics for the Chinese P h a r m a c e u t i c a l C o m p a n y H i s u n Pharmaceutical. CORPORATE Telstar completes its web site with the addition of project services information for the Life Sciences market Telstar integrates into its web site the Project Services of consultancy, engineering, construction and IT solutions, to better reflect the complete portfolio of the global solutions offered by the company Through the recent inclusion of detailed information of project services in the fields of consultancy, engineering, construction and IT solutions, Telstar's web site now contains information on all of its Life Sciences product and services. In the Life Sciences field, the Telstar web site is now organized to reflect and reinforce its position as a supplier of global integrated solutions. The website visual structure provides a rapid access to two main groups Technology Equipment and Project Services- to simplify user-access to the information. Also, the structure of the site enables market oriented access to the information; Pharmaceutical Industry, Laboratory and Hospital. The uniqueness of Telstar lies in its capacity to offer complete global solutions in consultancy, engineering, construction and IT solutions, and also integrated process equipment solutions developed using its inhouse technologies, for pharmaceutical applications. In essence the Telstar web site is constantly evolving in response to the nature of its business and the markets it serves. The updating process of the website has also provided the opportunity to incorporate social networks and give greater emphasis to multimedia resources.
3 VACUUM SOLUTIONS New! Telstar provides a simulation chamber for vacuum thermal tests on micro-satellites -7 The chamber can reach a vacuum level of 10 mbar and the temperature range extends from -180 C to +180 C Telstar has developed and supplied a space simulation chamber for Instituto Universitario de Microgravedad Ignacio da Riva, in Universidad Politécnica de Madrid. Featuring a test chamber 1.0 meters in diameter and 1.4 meters in length, this system is intended for space simulation tests and behavior analysis of microsatellites and other space equipment, under thermal and vacuum conditions which simulate the actual conditions present in space. The system can be used for qualification tests (using qualification models not intended for launch) and for acceptance tests (using models that will be launched into space). The chamber can reach a vacuum level of 10-7 mbar, which is equivalent to one- 10,000-millionth of an atmosphere. The temperature range extends from -180 C to +180 C. These conditions expose space systems and equipment to stress levels similar to those that will be found in space, where the satellite is exposed to solar radiation without atmospheric protection, and to an extremely cold environment when shadowed by the Earth. LIFE SCIENCE SOLUTIONS - Laboratory Telstar develops a containment unit for use in biomedical research at the CSIC, Institute of Materials Science of Barcelona Telstar has developed and supplied a containment unit for the Institute of Materials Science of Barcelona (ICMAB), which belongs to the National Research Council (CSIC) that will be used for the preparation of micro and nanoparticulate materials and nanomedicines used in biomedical research. The unit is a four glove dispensing isolator; the first of its kind at the institute, which will be used by Nanomol research group, from ICMAB. The system utilises standard Isolator design features for ventilation, visor panels, safe-change gauntlets and filtration and is integrated with a custom control system, including Siemens PLC and HMI touch screen, to provide the level of operator interface expected in today's technological arena. Pressure and air monitoring instruments are linked via PLC to the main air controls, to maintain appropriate air quality during operation. In addition, wash-gun features facilitate thorough clean down between products. The unit will achieve operator exposure levels of <0.1µg/m³, which will enable highly active and hazardous products to be processed. The isolator developed by Telstar provides the full capability to handle the technology developed by Nanomol over the past few years, and enables nanoprocessing of cytotoxic molecules, such as the one developed under ORALBEADS collaborative project funded by the program INNPACTO 2011 MINECO (Spanish Ministry of Economy and Competitiveness). This project is coordinated by the Spanish company Pharmamar, a leader in the development of antitumor drugs of marine origin.
4 LIFE SCIENCE SOLUTIONS - Pharma Telstar develops three integrated lines for bulk production of potent sterile antibiotics for Hisun Pharmaceutical LIFE SCIENCE SOLUTIONS - Pharma Chinese firm Zhejiang Hisun Pharmaceutical Co. Ltd. is a major international manufacturer of APIs (Active Pharmaceutical Ingredients) This is the largest integrated project using proprietary dosing, freeze-drying, sterilisation, unloading and packing technologies. Telstar has successfully developed three integrated production lines incorporating proprietary dosing, freeze-drying, unloading and end packing technologies for the manufacture of bulk sterile antibiotics for Hisun, one of the largest Chinese producers of APIs (Active Pharmaceutical Ingredients). This is the largest integrated project to be carried out in China in which a single company, Telstar, provided all of the technology for the entire primary packaging process. The integrated freeze-drying system features an automatic loading and unloading system operating under sterile conditions within a production isolator. Specifically designed for the freeze-drying of antibiotics, the system incorporates a sterile isolator which protects the operator and provides an ISO 5 class manufacturing environment. Production operations are carried out by automation systems inside the isolator so the risk of contamination during human manipulation of the product is eliminated, while the operators are also protected from the potency of the product. The first stage of the process (freeze-drying) is composed of three GMP production freeze-dryers and automatic tray loading and unloading systems installed inside sterile isolators, together with equipment to dispense the liquid product into trays. After the freeze drying cycle is complete, vacuum unloading systems move the freeze-dried product into IBC containers. The project also includes steam autoclaves and various RAB (Restricted Access Barrier) and isolator systems necessary for other applications associated with the production process. The second stage of the process involves weighing and packing support for each of the freeze-drying systems. An integrated autoclave is used to steam-sterilize aluminium canisters, which are then dosed from the IBC with a weighed quantity of the freeze-dried product. Packing then completes the process, all of which will operate within an isolator to guarantee operator safety and ISO 5 classification. Telstar has supplied this complete system in triplicate, thereby giving the client greater flexibility in carrying out large-volume production. Also designed into the system is the possibility to expand the production in the future by incorporating new freeze dryers and sharing much of the existing equipment. Telstar's capability to develop and manufacture this system entirely in-house provides the client with a cost-effective solution and assures quality control over the whole process. LIFE SCIENCE SOLUTIONS - Services Square Pharmaceuticals contracts Telstar for the development of new plants for production of oral and parenteral products Bangladesh's largest pharmaceutical company consolidates its leadership in the Asian continent Telstar is managing the full execution of two new pharmaceutical plants for the international Bengali company Square Pharmaceuticals. For the first project, Telstar is managing the construction of a plant for the production of oral solids consisting of a 2 four-story building of 32,000 m with 7 fluidized bed granulation lines, 11 tablet lines, 4 lines for capsules, and 16 primary and secondary packaging lines, plus a second 2 service building of 1,000 m. The second project consists of a 20,000 m 2 four-story building for production of parenterals in small and large volume formats, including two lines for manufacturing BFS bottles with two reactors of 20,000 litres each, a line for manufacturing glass bottles, one for bags, two for vials, two for preloaded syringes, one for lyophilized vials with two freeze-dryers and one topical aerosol production line. Telstar performed the engineering for both plants and was the winning bidder for the full project administration and provision of the pharmaceutical architecture and the process equipment and critical installations; managing the coordination of local installers for the remaining installations. Square Pharmaceutical's trust in Telstar as a technological partner is based on its knowhow, experience and capability in the development of these types of large scope projects. Since 2003, Telstar has collaborated with Square on a number of high-complexity projects which involved the development of production installations and plants. Outstanding examples include the new cephalosporin plant built in 2005, the new plant for sterile filling and bottling of pharmaceutical liquids with Blow-Fill-Seal (BFS) technology in 2007, the new insulin production plant in 2010 (with the ability to produce up to 13 million vials of insulin per year) and, finally, the SVPO plant for production of small volume parenterals and ophthalmology products inaugurated in 2008 in Dhaka. Square Pharmaceuticals Limited is the largest manufacturer of pharmaceutical products in Bangladesh. The most prominent company of the Square Group since its founding in 1958, it has experienced solid growth leading it to its current leadership position in its country and in the Asian continent. With a market share of 18.71%, Square Pharmaceuticals obtained a sales volume of approximately 212 million dollars in 2011.
5 LIFE SCIENCE SOLUTIONS - Services LIFE SCIENCE SOLUTIONS - Services Telstar reinforces its pharmaceutical consulting area by adding a new line of consulting and deployment services for quality by design (QbD) systems Having completed the acquisition process of dtc Development Team Consulting, Telstar strengthens its ability to develop quality systems in GXP environments The company has also enhanced its consulting and deployment service for R&D and pharmacovigilance quality systems Telstar consolidates its standing as the only company capable of offering a global and comprehensive pharmaceutical consulting service Telstar has reinforced its pharmaceutical consulting area by driving two new business lines that will offer consulting services for quality systems in GXP environments. Specifically, Telstar has incorporated a new Quality by Design (QbD) deployment service, and has expanded its R&D quality systems service for the preclinical (GLP) and clinical (GCP) phases in the development of active ingredients and drugs, as well as for pharmacovigilance in the marketing phase. The expansion of Telstar's consulting services portfolio took place on February 1, 2013, when the Catalonian company acquired dtc Development Team Consulting's business. dtc Development Team Consulting, which has been in business since 2000, is highly specialized in executing projects that deal with GXP regulatory compliance and with the improvement of manufacturing processes based on Quality by Design concepts. With the integration of dtc's know-how into its business, Telstar now stands strengthened as the only Spanish company capable of offering a global pharmaceutical consulting service that encompasses the entire drug life cycle. Quality by Design in product development, manufacturing and marketing of drugs and API's is a win-win strategy oriented toward achieving robust and efficient processes, which leads to a quality assurance for the product with costs optimization. Efficiency in manufacturing processes reduces inspection efforts and product related non-quality costs. It is a highly competitive methodology when compared with the traditional quality assurance system based primarily on final inspection and control, which is clearly less efficient. The regulatory framework to work in QbD is firmly established, and the latest GMP updates require adapting quality systems to the new, risk management-based models, and adapting production systems to permit continuous process monitoring and verification. In fact, and as of January 2013, the US FDA requires the use of QbD methodology for the drug marketing authorization process of generic products. The integration of this specialized service enables Telstar to position itself as a leading provider of GLP services for nonclinical development, GCP services for clinical development, QbD services for process development and redesign, PAT/NIR services for process monitoring and control and GMP services for GMP production and operational excellence. The full range of Telstar's consultation services has now been consummated by the incorporation of these two business lines, with services related to Regulatory Affairs and Compliance in the life sciences sector.
6 EXHIBITIONS AND CONFERENCES Laborama Groot-Bijgaarden(Holland) Medtec Stuttgart (Germany) PharmTech, Moscú (Russia) Pharma Congress Düsseldorf (Germany) 22nd Annual Vendro Night, San Francisco (USA) ISPE Critical Utilities, Florida (USA) Interphex NYC, Nueva York (USA) ISPE Annual Meeting, Washington (USA) CGMP Conference, Baltimore (USA) Forum Labo & Biotech Paris (France) A3P Pau(France) Farmamaq Zaragoza (Spain) AEFI, Barcelona (Spain) era, Rome (Italy) ArabLab, Dubai (UAE) Asian Pharma Expo, Dhaka (Bangladesh) ISPE Annual Conference, Beijing (China) CIPM, Qingdao (China) Analytica Vietnam, Ho Chi Minh (Vietnam) ISL-FD, Sao Paulo (Brazil) Farmamaq: 13 February, Zaragoza (Spain) Asian Pharma Expo: February, Dhaka (Bangladesh) ISPE Critical Utilitites: February, Tampa (USA) Medtec: February, Stuttgart (Germany) Arablab: March, Dubai (UAE) 22nd Annual Vendor Night: 14 March, Baltimore (USA) Laborama: March, Groot-Bijgaarden (Holland) Laborama: March, Groot-Bijgaarden (Holland) Pharma Congress: March, Düsseldorf (Germany) A3P: 3 April, Pau (France) era: April, Rome (Italy) Analytica Vietnam: April, Ho Chi Min City (Vietnam) ISPE China Annual Conference: April, Beijing (China) Interphex NY: April, New York (USA) CIPM: April, Qingdao (China) Coming Exhibitions May 2013 June 2013 July 2013 L M M J V S D AEFI, Barcelona (Spain) L M M J V S D Forum Labo & Biotech, Paris (France) CGMP Conference, Baltimore (USA) L M M J V S D Pharma Congress, Düsseldorf (Germany) ISPE Critical Utilities, Tampa (USA) ArabLab, Dubai (UAE) Edited by: TELSTAR TECHNOLOGIES, S.L. Photographs: TELSTAR TECHNOLOGIES, S.L National Book Catalogue Number: B TELSTAR TECHNOLOGIES, S.L. Av/ Font i Sagué, Terrassa (España) T F telstar@telstar.eu
Azbil Telstar opens its new subsidiary in Bangladesh
. May 2014 Number 26 www.telstar.com CORPORATE Azbil Telstar opens its new subsidiary in Bangladesh The company reinforces its leading position in Asia The Azbil Telstar subsidiary in Dhaka, Bangladesh,
More information2015 FOYA Award for facility integration Multipurpose Biologics and Vaccines Production Facility. IDT Biologika 2015 FOYA Award Facility Integration
2015 FOYA Award for facility integration Multipurpose Biologics and Vaccines Production Facility 1 Agenda ABOUT IDT BIOLOGIKA FACILITY HIGHLIGHTS AND INNOVATIVE FEATURES BUILDING CONCEPT AND PROJECT OVERVIEW
More informationBrand Quality with Asian Advantages
Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : mkt@scinopharm.com
More informationPrinciples. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg
Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new
More informationPharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success
Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals
More informationAn Industry White Paper
Driving Continuity and Collaboration from Lab Floor to Plant Floor to Top Floor An Industry White Paper Who is AspenTech? AspenTech is a global company founded in 1981 with more than 1,300 employees in
More informationLyoBeta. R+D Freeze-Dryers
LyoBeta R+D Freeze-Dryers LyoBeta series A Responsible Choice New demands in R+D centers are related to scale-up feasibility and quality of procedures and research methods. FDA investigators consider that
More informationThe essential choice in cell processing
The essential choice in cell processing Established in 1997 The Biosafe Group is an internationally active medical technology company with its roots in the Lake Geneva region of Switzerland. Since it was
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time
More informationCOMPANY P R O F I L E
COMPANY PROFILE 1. BRIEF PRESENTATION OF THE GROUP Fedegari Autoclavi SpA is the holding company of an Italian industrial group manufacturing customized machines, plants and the relevant components for
More informationTelstar acquires Usifroid and takes a major step into the French market
July 010. Number 1 TELSTAR GROUP www.telstar.eu Telstar acquires Usifroid and takes a major step into the French market Telstar has acquired French company Usifroid, which is internationally recognized
More informationHow companies leverage quality and quality certifications to achieve competitive advantage
How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for
More informationPharma & Biotech processes: global turnkey solutions
Pharma & Biotech processes: global turnkey solutions 02 Our mission: to design and build turnkey process solutions AS A LEADING-EDGE INDUSTRIAL INTEGRA- TOR, BOCCARD DESIGNS AND BUILDS UNIQUE PHARMACEUTICAL
More informationC 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
More informationHigh Potent Drugs & Containment Technology
High Potent Drugs & Containment Technology Technology Overview & Quality Risk-Based Design Selection Holger Fabritz Head of Quality & Validation Assurance Part 1 Definition High Potent Drugs, OEL & hazardous
More informationGAMP5 - a lifecycle management framework for customized bioprocess solutions
GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),
More informationEngineering for the new pharma reality
NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have
More informationAnnual Report on Form 20-F
Annual Report on Form 20-F 2 Teva at a Glance Founded in 1901 by three young pharmacists, today Teva Pharmaceutical Industries Ltd. is a leader in the global pharmaceutical industry, providing medicines
More informationTechnology 21,000. 1.2 m Contacts. Technology trade fairs and events. Organiser. Points of view. Trade fairs. www.technology.messefrankfurt.
Technology Technology trade fairs and events 21,000 Points of view 70 Trade fairs 1 Organiser 1.2 m Contacts www.technology.messefrankfurt.com Innovative world of events High-tech meets know-how. Innovation
More informationSterile operation scenarios at GSK-Parma
Sterile operation scenarios at GSK-Parma R.Cassaniti, N.Trivelli, M.Bini - GSK manufacturing S.p.A. Dexterous Manipulation in hazardous areas workshop- Lyon 21/3/2013 Property of GlaxoSmithKline GSK-Glaxo
More informationPHARMACEUTICAL AND CHEMICAL WASTE MANAGEMENT
Medicines and Medical Devices Agency of Serbia PHARMACEUTICAL AND CHEMICAL WASTE MANAGEMENT Ivana Bozic, MSc Health, Safety and Environment ISWA Beacon Conference, Novi Sad, 08 10 December 2010 458, Vojvode
More informationValentina Gualato, Ph.D. Process Development Scientist
COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE
More informationPlanning Engineering Projects management of Pharmaceutical Plants
Planning Engineering Projects management of Pharmaceutical Plants Contrà S. ANNA 1/5 35012 CAMPOSAMPIERO (PD) www.tsaonline.it tel. 0039-0495792435 fax 0039-0499306065 Chemical and Pharmaceutical Engineering
More informationContinuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens.
Continuous manufacturing moving towards real-time release Creating innovations for the pharmaceutical industry siemens.com/pharma Strategic partnership Creative ideas and industry expertise A move to continuous
More informationManagement Policies of Nippon Express. March 2007
Management Policies of Nippon Express March 2007 1. Our Group's Business Framework 1. Our Group's Business Framework Nippon Express Group Overseas Japan Asia-Oceania Europe Americas Domestic transport
More informationNEW CHEMICAL ENTITIES
NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product
More informationThis entry into the world of ecological and green ultra-freezing further expands Telstar's
EXHIBIION AND CONERENCE Achema & IPE Aseptic Processing rankfurt elstar, a global perspective hen I travel around the world and meet our staff, agents, distributors, collaborators and clients, one of my
More informationOvercoming Challenges in the Manufacturing of Pre-Filled Syringes. Farvea, a new comer in the PFS world PFS Tech 2016. June 2016 pharma@fareva.
Overcoming Challenges in the Manufacturing of Pre-Filled Syringes Farvea, a new comer in the PFS world PFS Tech 2016 June 2016 pharma@fareva.com Our presence around the world 11 countries 35 sites 12
More informationMedical Waste Management Issues in Asia
Medical Waste Management Issues in Asia C. Visvanathan Environmental Engineering & Management Program Asian Institute of Technology Thailand 1 visu@ait.ac.th Web: http://www.faculty.ait.ac.th/visu/ Asia
More informationAlgoritmos Procesos y Diseños S.A. +25 years developing tailored-made solutions for the Healthcare Community. Healthcare division
+25 years developing tailored-made solutions for the Healthcare Community Healthcare division Our Values Sucesful track-record improving clinical efficiency and financial performance One of the key suppliers
More informationGMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE
More informationTelstar has built the most advanced space simulation chamber in the south hemisphere
April 2009. Number 19 www.telstar.eu VACUUM Telstar has built the most advanced space simulation chamber in the south hemisphere Telstar has designed and developed the most advanced space simulation chamber
More informationE-commerce liberalization in China: State Council and MIIT push forward
E-commerce liberalization in China: State Council and MIIT push forward Contents State Council orders government agencies to take liberalization steps 1 JUNE [ MIIT removes foreign ownership restrictions
More informationHealthcare Company. Business Strategy
Panasonic IR Day 2012 Healthcare Company Business Strategy May 23, 2012 Panasonic Corporation Healthcare Company President Kenji Yamane Notes: 1. This is an English translation from the original presentation
More informationCompany background and. portfolio overview
Company background and portfolio overview A world leading company in infection control Steelco products are used daily in over 100 countries within the Healthcare, and Life Science sectors to provide the
More informationTable of Contents. Presented by
Improving Markets, Services, and Technologies Table of Contents Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035 Fax: (408) 978-8925 www.hightechdecisions.com
More informationRegional Strategies 82/90
Regional Strategies 82/90 Global Operations NTT Com Group has subsidiaries and offices in 85 cities in 30 countries/regions except Japan, which connect networks to more than 150 countries around the world.
More informationFuture 1988 1992 1996 1998 1999 2000 2002-2003 2004-2005 2006-2007 2008 2010 2011 2012-2013
Company Profile Innovative Motion Control about etel With the largest direct drive motor range available on the market, ETEL provides solutions ranging from high-end motion systems with nanometer precision,
More informationAnnouncement of Completion of Heraeus Holding GmbH s Dental Materials Business Share Purchase
July 1, 2013 Mitsui Chemicals, Inc. Announcement of Completion of Heraeus Holding GmbH s Dental Materials Business Share Purchase Mitsui Chemicals, Inc. (Toshikazu Tanaka, President & CEO) announced in
More informationGerman engineering under high pressure
German engineering under high pressure Over 25 years of experience as a manufacturer of sterilizers, autoclaves and lyophilization systems for laboratories, production and research Production-scale autoclaves
More informationFILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS
FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer
More informationINDEX SERIES FTSE PUBLICATIONS. FTSE ETF Issuer Services.
INDEX SERIES FTSE PUBLICATIONS FTSE ETF Issuer Services. BEIJING BOSTON DUBAI HONG KONG LONDON MILAN MUMBAI NEW YORK PARIS SAN FRANCISCO SHANGHAI SYDNEY TOKYO FTSE FTSE Group ( FTSE ) is a world-leader
More informationSEFAR PHARMA GMP solutions Life Science
SEFAR PHARMA GMP solutions Life Science Sefar Life Science Solutions Sefar responded to the stringent requirements of the pharmaceutical industry by creating the highest quality standards available. Developed
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationCatalent Biologics & Clinical Supplies The SMART Solution
Catalent Biologics & Clinical Supplies The SMART Solution Advanced Technology and Integrated Solutions From DNA to Clinical Supply & Cold Chain Distribution Dr. Florian Schwaak Account Manager Germany
More informationLiquids Suspensions Gels
Liquids Suspensions Gels EMCM: your product development and manufacturing partner Centre of excellence European Medical Contract Manufacturing (EMCM) is the centre of excellence in developing and manufacturing
More informationDCC Overview DCC is an international sales, marketing, distribution and business support services group operating across four divisions
Company Overview DCC Overview DCC is an international sales, marketing, distribution and business support services group operating across four divisions Profit by division * Profit by geography * 14% 4%
More informationBio Deutschland CEO & CFO-Meeting 29. November 2012. Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec
Bio Deutschland CEO & CFO-Meeting 29. November 2012 Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec Major locations Köln Our Passion SHARING OUR PASSION FOR CELLS We
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationContinuous Granulation and Drying
Continuous Granulation and Drying Collette TM Technologies GEA Pharma Systems GEA Pharma Systems supplies advanced technologies for the processing of Active Pharmaceutical Ingredients (API) for the production
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationAuditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
More informationHighly Potent APIs The right platform, people and procedures for successful development and manufacturing
Pharma&Biotech Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Custom Manufacturing and Development Services for Highly Potent APIs Pharma&Biotech
More informationBiopharm Roundtable. 1. What, in your opinion, is currently the single largest trend with respect to biopharmaceutical outsourcing and manufacture?
BIOPHARM ROUNDTABLE Biopharm Roundtable Morrey Atkinson Vice President, R&D Cook Pharmica Peter Soelkner Managing Director Vetter Pharma-Fertigung GmbH & Co. KG Johannes Reiter Cooperations Manager Sandoz
More informationSterile and Ready-to-fill Glass Containers with new Packaging and Connection Solutions
Sterile and Ready-to-fill Glass Containers with new Packaging and Connection Solutions 0. Summary The last 30 years have witnessed continuous updates and innovation in the pharmaceutical packaging and
More informationNon-GMP and GMP Services From Lab Scale R&D to Bulk API Production
Non-GMP and GMP Services From Lab Scale R&D to Bulk API Production (grams to tons) International and All Encompassing Facilities in Asia, Europe, and North America One Stop Manufacturing from Lab to Commercial
More informationCyber security: A major issue for Australian business
Cyber Security: A major issue for Australian business: February 2016 1 Cyber security: A major issue for Australian business Contents Introduction and background Is your industry particularly vulnerable
More informationPresented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
More informationhistaris Inline Sputtering Systems
vistaris histaris Inline Sputtering Systems Inline Sputtering Systems with Vertical Substrate Transport Modular System for Different Applications VISTARIS Sputtering Systems The system with the brand name
More informationSTATIM G4 Cassette Autoclaves From start to dry in the blink of an eye.
STATIM G4 Cassette Autoclaves From start to dry in the blink of an eye. STATIM, the world s fastest autoclave from start to sterile Drawing on over 20 years of innovation, Healthcare practitioners in over
More informationICH Q7 GMP for Active Pharmaceutical Ingredients
National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses
More informationCompany Presentation
Company Presentation DISCLAIMER This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of amp biosimilars
More informationStrategic Growth. Enduring Trust.
Strategic Growth. Enduring Trust. A Balanced Portfolio for Lasting Success Founded in 1998, AmTrust Financial Services, Inc. was created to provide insurance products to small businesses. Through smart
More informationLaboratory- and sterilisation equipment HMC EUROPE
Laboratory- and sterilisation equipment HMC PROFILE HMC Laboratory- and sterilisation equipment Consistent marketing of technologies and the conversion of new ideas create product ranges, that are tailor-made
More informationOur Financial Services Regulatory practice
Our Financial Services Regulatory practice 2015 2 Our Financial Services Regulatory practice 2015 Allen & Overy LLP 2015 3 How we can assist you Ranked Tier 1 for Financial Services Regulatory: Non-contentious
More informationSpecial Feature: Growth Model of an Agile Company
Special Feature: Growth Model of an Agile Company 15 Sysmex s Global Strategy From the time of its establishment, Sysmex has followed a steady growth trajectory, and the Group now provides products and
More informationAn integrated global healthcare company
An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment
More informationEditorial Calendar 2014
Editorial Calendar 2014 IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com website for Peer Review Protocol and Authors Guidelines. The topics and subjects
More informationBarcode Labeling in the Lab Closing the Loop of Patient Safety
Barcode Labeling in the Lab Closing the Loop of Patient Safety INTRODUCTION Detecting and preventing errors that threaten patient safety is a closed-loop process that begins at the point of care, extends
More informationParticle Monitoring Requirements in Pharmaceutical Cleanrooms
Particle Monitoring Requirements in Pharmaceutical Cleanrooms All drugs must be manufactured in accordance with the current Good Manufacturing Practice (cgmp) regulations. Pharmaceutical manufacturers
More informationCelCulture. CelCulture CO2 Incubator Model CCL-170_-_. CO2 Incubator with Integrated Cooling System Solution for Highly Specialized Applications
1 CO2 Incubator Model CCL-170_-_ CO2 Incubator with Integrated Cooling System Solution for Highly Specialized Applications Welcome to Esco Esco s Vision is to provide enabling technologies for scientific
More informationACB SERIES MAIN CHARACTERISTICS OF THE STERILIZER : CONTINUOUS STERILIZERS
CONTINUOUS STERILIZERS ACB SERIES MAIN CHARACTERISTICS OF THE STERILIZER : > COST SAVER (LOW ENERGY AND LOW LABOUR) > FULLY AUTOMATED > HIGH QUALITY FINAL PRODUCTS > FLEXIBLE AND VERSATILE (FROM 100 ML
More informationImproving Uptime in Aseptic Processing of Pharmaceutical Liquids with Blow-Fill-Seal
Improving Uptime in Aseptic Processing of Pharmaceutical Liquids with Blow-Fill-Seal Maximized uptime, minimized changeover time and efficient OEE are key factors that have influenced the acceptance of
More informationICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010
ICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010 Joseph C. Famulare Head of External Relations and Collaboration Pharma Global Technical Operations Global Quality, F. Hoffmann-La
More informationSupply Chain Challenges and Risk Management
Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7
More informationTelefónica Open Future, China Unicom and THTI launch a joint global call to accelerate startups in the IoT space
Telefónica Open Future, China Unicom and THTI launch a joint global call to accelerate startups in the IoT space The three companies, which already have an agreement to promote open innovation, will also
More informationCHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
More informationCase Study Neubau einer Parenteralia Fabrik 3. GMP-Forum, Kirchzarten 28. September 2012, Basel. Philip Schneider, F.
3. GMP-Forum, Kirchzarten 28. September 2012, Basel Philip Schneider, F. Hoffmann-La Roche Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing
More informationNEWS & NOTES. Autumn 2002. Vol.22. Total Engineering Technology, Kajima-Style
NEWS & NOTES Autumn 2002 Vol.22 Total Engineering Technology, Kajima-Style Elevations Total Engineering Technology, Kajima-Style Engineering Capability Attuned to the Times The industrial world is beset
More informationRegulated Applications in the Cloud
Keith Williams CEO Regulated Applications in the Cloud Aspects of Security and Validation Statement on the Cloud and Pharma s added Complexity Clouds already make sense for many small and mediumsize businesses,
More informationDISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION
1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information
More informationBiotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
More informationApplication Of Quality Metrics In Determining Overall State Of Quality. & The Health Of Associated PQS FDA s Current Thinking
Course Objectives: How does industry use Metrics? FDA Challenges and equirements and Use of Quality Metrics Complexities of Implementation (Industry Feedback) What does it all mean? Key in isk identification
More information2010 Critical Thinker Series
Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series
More information11º FORO MEDCAP R&D Medium Cap Leaders. Madrid, May 27, 2015
11º FORO MEDCAP R&D Medium Cap Leaders Madrid, May 27, 2015 01. A NEW COMPANY A NEW COMPANY Established: 2002 Spin-off from Natra Sector: Food supplements 2013 sales: 31.4 M 2013 EBITDA: 2.6 M Established:
More informationBarcode-Based Patient Safety Initiatives in Hospital Pharmacies
Barcode-Based Patient Safety Initiatives in Hospital Pharmacies INTRODUCTION Maximizing patient safety and improving the quality of care is the ultimate goal for healthcare providers and extends to the
More informationPHARMACY TECHNICIAN COURSE DESCRIPTIONS
PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE
More informationC. Medium-term Management Plan. Copyright 2015 NTT DATA Corporation 28
C. Medium-term Management Plan Copyright 2015 Corporation 28 Copyright 2015 Corporation 29 Targets for the Medium-term Management Plan Target figures for the Medium-term Management Plan (FY Ending March
More informationIndian E-Retail Congress 2013
The Retail Track The Omni Channel Retail Supply Chain Indian E-Retail Congress 2013 Subhendu Roy Principal Consumer Industries and Retail Practice 15 February, 2013 Disclaimer This document is exclusively
More informationDraft guidance for registered pharmacies preparing unlicensed medicines
Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies
More information. ABOUT AS http://www.italtel.com/aboutus_home.html
. ABOUT AS http://www.italtel.com/aboutus_home.html COMPANY PROFILE THE MISSION The mission of the Italtel Group is to be a key partner for telecommunication operators (fixed and mobile), Internet Service
More informationCleanroom. For. Sterile Manufacturing Facilities
Cleanroom For Sterile Manufacturing Facilities Praphon Angtrakool Food and Drug Administration 1 WHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried
More informationdirect sales effectiveness through sector focus
Strategic Report Our strategy in action In this section we demonstrate how we are implementing and making progress against each of our six strategic themes. 1 Increase direct sales effectiveness through
More informationCustom Synthesis. Reliable, Flexible and Competitive THE KEY SOLUTION PROVIDER A FINE CHEMICAL COMPANY. About ISOCHEM
Custom Synthesis Reliable, Flexible and Competitive About ISOCHEM ISOCHEM manufactures products and offers services that meet the most recent and stringent regulatory standards of the Pharmaceutical industry.
More informationOn-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
More informationMarken For more information visit: www.marken.com
ceocfointerviews.com All rights reserved! Issue: January 18, 2016 The Most Powerful Name in Corporate News Global Supply Chain Service Provider to the Pharmaceutical and Healthcare Industry We are tracking
More informationH1 2015 Audio webcast RESULTS PRESENTATION. July 30, 2015
H1 2015 Audio webcast RESULTS PRESENTATION July 30, 2015 DISCLOSURE This presentation contains no confidential material and may include publicly available market information which has not been independently
More informationMicrobiology and Auditing. Don Singer
Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning
More informationGuide to The Notification System for Exempt Medicinal Products
Guide to The Notification System for Exempt Medicinal Products AUT-G0090-1 10 JULY 2014 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More information